Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$19,349,102
+$1,547,763 QoQ
Shares Held
76,892
-6.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
3.14%
of 13F equity value
Holder Rank
#627
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ZEVIN ASSET MANAGEMENT LLC holds $59,856,217 across 9 Drug Manufacturers - General names. ABBV ranks #1 (32.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
76,892 | $19,349,102 | |
| 2 | LLY |
ELI LILLY & Co
|
12,300 | $14,752,990 | |
| 3 | NVS |
Novartis AG
|
74,291 | $11,642,885 | |
| 4 | AZN |
Astrazeneca PLC
|
58,678 | $11,126,522 | |
| 5 | AMGN |
Amgen Inc
|
3,256 | $1,179,062 | |
| 6 | MRK |
Merck & Co., Inc.
|
5,318 | $683,363 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,006 | $506,118 | |
| 8 | PFE |
Pfizer Inc
|
14,641 | $352,555 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,349,102 | 76,892 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $17,801,339 | 81,849 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $18,855,451 | 82,522 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $20,139,117 | 86,979 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $17,010,588 | 91,642 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $17,075,460 | 81,498 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $14,694,190 | 82,691 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $15,013,022 | 76,023 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $13,256,952 | 77,291 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $14,899,239 | 81,819 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $12,803,311 | 82,618 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $12,366,762 | 82,965 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $10,908,953 | 80,969 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $12,827,691 | 80,490 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $13,384,216 | 82,818 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $11,349,737 | 84,567 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $12,628,501 | 82,453 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $13,999,981 | 86,361 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $12,299,194 | 90,836 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $9,675,831 | 89,699 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $9,359,933 | 83,096 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $8,711,277 | 80,496 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $8,364,343 | 78,062 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $6,577,746 | 75,097 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $7,164,292 | 72,971 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $5,542,365 | 72,744 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||